Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models
- 15 April 1988
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
- Vol. 959 (3) , 332-342
- https://doi.org/10.1016/0005-2760(88)90207-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- An alternate mechanism for regulation of leukotriene production in leukocytes: studies with an anti-inflammatory drug, sodium diclofenacBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Role of lipoxygenase products in murine pulmonary granuloma formation.Journal of Clinical Investigation, 1984
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984
- The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.Journal of Clinical Investigation, 1984
- Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical modelsBiochemical and Biophysical Research Communications, 1983
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Leukotriene B4 induces human suppressor lymphocytesBiochemical and Biophysical Research Communications, 1982
- Leukotriene B4 in synovial fluidJournal of Pharmacy and Pharmacology, 1982
- Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.Journal of Clinical Investigation, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980